Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLBT

SL Science Holding Ltd

Last Close
3.06
Aug 04 • 9:52 AM ET Dollar change-0.23 Percentage change(-6.87%)
Aug 03, 2:03 PMMomentum from July gamma delta T-cell brain cancer data drives SLBT 25% surge
Index
-
Market Cap
1.72B
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Jun 15, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
59.54%
Insider Trans
0.00%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-15.29%
SMA50
-25.89%
SMA200
-25.89%
Trades
Shs Outstand
560.76M
Shs Float
226.91M
52W High
14.50 -78.87%
52W Low
2.54 20.79%
Volatility
14.21% 13.19%
ATR (14)
0.73
RSI (14)
47.29
Beta
-
Rel Volume
0.80
Avg Volume
1.32M
Volume
114,912
Perf Week
11.42%
Perf Month
-35.02%
Perf Quarter
-
Perf Half Y
-
Perf YTD
-23.40%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
3.29
Price
3.06
Change
-6.87%
SL Science Holding Ltd. offers cell and gene technologies to improve cell therapy effectiveness. The private company is located in the US.
FounderMr. Ching-Dong Wang
CFO & DirectorMr. Ray Leung
CTO & DirectorDr. Ethan Shen Ph.D.